Zimbabwe has declined a major American healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years due to the United States' insistence on sensitive data.
The decision was revealed after a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa deemed the agreement was "lopsided".
An official spokesperson has since explained that the US was demanding access to genetic material for scientific study and commercial gain while refused to share the benefits from any future vaccines.
"We must now begin the difficult and regrettable process of scaling back our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has appealed for continued negotiations to find a deal suitable to all parties so the nation's vital HIV treatment initiative can continue.
Wider Implications
Zimbabwe's decision follows a comparable situation in Kenya, where a court halted a related deal with the US following concerns were raised about the safety of Kenyans' medical information.
After returning to the presidency last year, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
The agency had administered assistance for the American government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to boost transparency and accountability.
According to statements, Sixteen nations in Africa have so far signed these new agreements, constituting over $18.3bn in new funding.
Specifics of the Rejected Deal
This assistance for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation would have delivered extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on HIV treatment via US-supported initiatives," Tremont said.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, with no equivalent guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.
"Put simply, our nation would supply the raw materials for scientific discovery without any assurance that the final treatments would be available to our population should a future disease outbreak arise."
National Interest and International Frameworks
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were upending systems already set up via the international health agency.
Mangwana cited its Pandemic Benefit-Sharing scheme created to deal with future pandemics.
"This mechanism is intended to guarantee that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to develop them."
The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome further discussions with our US partners on how subsequent co-operation could be arranged in a manner that honours the sovereignty and dignity of both nations."
Medical Community Reaction
Medical experts expressed it recognised the government's concerns, but recommended that talks must proceed considering a large portion of the country's HIV programmes were funded by external financing.
"If technical issues arise, including those involving data governance or implementation frameworks, these can frequently be resolved through technical clarification and mutually agreed protections," it commented.
The situation highlights the complex debate between accepting much-needed foreign assistance and protecting local interests in an ever more interconnected world.